Clinical Trials in China / NCT04223466
Recruiting
Not applicable
Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Procedure
NCT04223466 · tracked via the Priya Life Science China tracker
Condition(s) studied
Thymectomy
Investigational drug(s) / intervention(s)
Subxiphoid surgery procedureVATS surgery procedure
Subxiphoid surgery procedure: Subxiphoid procedure for thymectomy
VATS surgery procedure: VATS procedure for thymectomy
Study summary
Surgerys used in thymectomy for myasthenia gravis and anterior mediastinal tumours have become much less invasive in recent years. In our study, the surgical technique which resected the thymus below the xiphoid process and the technique which was regarded as conventional video- assisted thoracoscopic surgery (VATS) thymectomy was compared.
Eligibility
Inclusion Criteria:
1. Thymoma with or without myasthenia gravis；
2. Generalized myasthenia gravis not sensitive to conservative medicine treatment;
3. Good cardiopulmonary function.
Exclusion Criteria:
1. Cardiopulmonary function can't bear surgery;
2. Generalized myasthenia gravis with MuSK(+).
Primary outcome measure(s)
- Visual Analogue Scale of postoperative pain — within 3 days
in score - Operation time — one day
in minutes - The amount of blood loss — one day
in milliliter - Duration of drainage — with 7 days
in days - Duration of hospital stay — with 7 days
in days
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Yunpeng | Jinan | Shandong | Recruiting |
More The Second Hospital of Shandong University trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04223466 on ClinicalTrials.gov ↗ ← All trials in China